Eli Lilly
Eli Lilly clarifies Mounjaro availability
Manufacturer moves to correct inaccurate reporting on the availability of Mounjaro Mandatory shortage reporting requirements for glucagon-like peptide-1 receptor agonist (GLP-1 RA) medicines is causing confusion about the availability …
‘King Kong’ drug Mounjaro now in short supply into 2024
Recently launched diabetes med with weight loss hype another victim of ‘larger than expected demand’ Mounjaro, the hotly anticipated competitor to social media-hyped diabetes and de facto weight loss drug …
Another diabetes drug scarce until end 2024
Eli Lilly’s Trulicity had been been ‘go-to’ replacement for in-demand Ozempic Trulicity, the type-2 diabetes preparation which had been a regular stop-gap option when the much-hyped Ozempic was in short …
World news wrapup: 21 September 2023
Eli Lilly takes action over copy-cat Mounjaro; Pope praises papal pharmacy staff; Pharmacist facing fraudulent export charges US: Pharmaceutical giant, Eli Lilly, is taking legal action against a number of …
Ozempic competitor to launch in spite of PBS knockback
Eli Lilly’s Mounjaro will be on the private scrip market by the end of September Revolutionary new type 2 diabetes drug Mounjaro – which is almost better known for producing …
Ozempic diabetes competitor gets PBS knockback
Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …
Twitter Blue’s health hoax meltdown
Drug company Eli Lilly’s share price drops 5% as fake account declares “free insulin” – while Australian state government “CHO” appears to bring back enforced mask wearing The shares of …